查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813793

美国器官晶片市场：市场规模、份额、趋势分析（按产品/服务、应用和最终用途）、细分市场预测（2025-2033）

U.S. Organ-on-a-Chip Market Size, Share & Trends Analysis Report By Product & Service, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国器官晶片市场概况

预计 2024 年美国器官晶片市值将达 7,170 万美元，到 2033 年将达到 9.404 亿美元，2025 年至 2033 年的复合年增长率为 33.14%。

这种成长的动力来自于对更具预测性的临床前测试模型的需求不断增长、动物测试的转变以及微流体、组织工程和个人化医疗的快速发展。

随着製药公司、生物技术公司和研究机构寻求更准确、更合乎道德和更具成本效益的方法来研究人体生理和疾病，器官晶片技术作为生物医学领域改变游戏规则的解决方案正受到越来越多的关注。

微流体和组织工程的进展

微流体和组织工程的进步是美国器官晶片产业发展的基础。微流体技术能够在微观尺度上精确控制营养素、药物和机械刺激的流动，忠实地模拟人体的动态状态。组织工程则对此进行了补充，利用人体衍生细胞创建3D细胞结构，这些细胞结构可以透过基因工程改造，在功能上类似于特定器官，例如肝臟、肺、心臟和肠道。这些技术进步显着提高了临床前试验的生理相关性，为研究人员提供了更具预测性和伦理责任性的疾病和药物反应研究工具。

干细胞技术，尤其是诱导性多功能干细胞(iPSC) 的整合，使得患者特异性模型的开发成为可能，进一步提升了器官移植平台 (OOC) 的价值。此类个人化晶片可以反映个体独特的基因变异和疾病表型，从而支持精准医疗。此外，近期的技术创新使得多个器官系统能够连接在单一晶片上，使研究人员能够研究药物和疾病如何以非孤立的方式影响人体。工程学与生物学的这种融合正在推动製药、生物技术和学术研究领域的持续需求。

目录

第一章 分析方法与范围

第二章执行摘要

第三章市场因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 产业分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章：依产品/服务进行的业务分析

  • 产品/服务细分仪表板
  • 美国器官晶片市场：产品与服务差异分析
  • 美国器官晶片市场规模与趋势分析（按产品/服务，2021-2033 年）
  • 产品
    • 产品市场估计与预测（2021-2033）
    • 装置
    • 美国的器官晶片设备
  • 服务
    • 服务市场估计与预测（2021-2033）

第五章 按应用程式进行的业务分析

  • 根据用途细分仪表板
  • 美国器官晶片市场：按应用进行的变化分析
  • 2021-2033年美国器官晶片市场规模及应用趋势分析
  • 药物研发
    • 药物研发市场估计与预测（2021-2033）
  • 毒性分析
    • 毒理学分析市场估计与预测（2021-2033）
  • 其他的
    • 其他市场估计与预测（2021-2033）

第六章 以最终用途分類的业务分析

  • 依最终用途细分仪表板
  • 美国器官晶片市场：按最终用途进行的变化分析
  • 美国器官晶片市场规模及趋势分析（依最终用途），2021-2033
  • 製药和生物技术公司
    • 製药和生物技术市场估计和预测（2021-2033）
  • 学术研究机构
    • 学术研究机构市场估计与预测（2021-2033）
  • 其他的
    • 其他市场估计与预测（2021-2033）

第七章 竞争态势

  • 公司分类
  • 战略地图
  • 企业市场分析（2024年）
  • 公司简介/上市公司
    • Emulate, Inc.
    • MIMETAS BV
    • Valo Health
    • Quris Technologies LTD.（Nortis, Inc.）
    • AxoSim
    • BICO-THE BIO CONVERGENCE COMPANY
    • CN Bio Innovations Ltd
    • The Charles Stark Draper Laboratory, Inc.
    • SynVivo, Inc.
    • AlveoliX AG
Product Code: GVR-4-68040-695-2

U.S. Organ-on-a-Chip Market Summary

The U.S. organ-on-a-chip market size was estimated at USD 71.7 million in 2024 and is projected to reach USD 940.4 million by 2033, growing at a CAGR of 33.14% from 2025 to 2033. This growth is driven by increasing demand for more predictive preclinical testing models, a shift from animal testing, and rapid advancements in microfluidics, tissue engineering, and personalized medicine.

As pharmaceutical companies, biotech firms, and research institutions seek more accurate, ethical, and cost-effective ways to study human physiology and disease, organ-on-a-chip technologies are gaining traction as a transformative solution across the biomedical landscape.

Advancements in Microfluidics & Tissue Engineering

Advancements in microfluidics and tissue engineering have become a foundational driver of growth in the U.S. organ-on-a-chip industry. Microfluidic technologies enable precise control over the flow of nutrients, drugs, and mechanical stimuli at a microscale, closely mimicking the dynamic conditions of the human body. Tissue engineering complements this by enabling the creation of 3D cellular structures using human-derived cells, which can be designed to functionally resemble specific organs like the liver, lung, heart, or gut. These innovations have significantly improved the physiological relevance of preclinical testing, offering researchers more predictive and ethically responsible tools for studying disease and drug response.

The integration of stem cell technology, particularly induced pluripotent stem cells (iPSCs), further enhances the value of OOC platforms by allowing the development of patient-specific models. These personalized chips can reflect genetic variations and disease phenotypes unique to individuals, supporting precision medicine approaches. Moreover, recent innovations have allowed multiple organ systems to be connected on a single chip, enabling researchers to study how drugs or diseases affect the body rather than in isolation. This convergence of engineering and biology fuels sustained demand across the pharmaceutical, biotech, and academic research.

U.S. Organ-on-a-Chip Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. organ-on-a-chip market report based on the product & service, application, and end-use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • Instrument
    • Devices
    • Liver-on-a-Chip
    • Lung-on-a-Chip
    • Intestine-on-a-Chip
    • Kidney-on-a-Chip
    • Heart-on-a-Chip
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
  • Toxicology Research
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product & Service Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in microfluidics & tissue engineering
      • 3.2.1.2. Increasing demand for disease modeling technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technical challenges and complexities associated with organ-on-a-chip technique
      • 3.2.2.2. Regulatory hurdles in organ-on-a-chip method
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Service Group Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. U.S. Organ-on-a-Chip Market Product & Service Movement Analysis
  • 4.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. U.S. Organ-on-a-Chip Devices
      • 4.4.3.1. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Liver-on-a-Chip
        • 4.4.3.2.1. Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Lung-on-a-Chip
        • 4.4.3.3.1. Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Intestine-on-a-Chip
        • 4.4.3.4.1. Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.5. Kidney-on-a-Chip
        • 4.4.3.5.1. Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.6. Heart-on-a-Chip
        • 4.4.3.6.1. Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.7. Others
        • 4.4.3.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Group Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Organ-on-a-Chip Market Application Movement Analysis
  • 5.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Toxicology Research
    • 5.5.1. Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Organ-on-a-Chip Market End Use Movement Analysis
  • 6.3. U.S. Organ-on-a-Chip Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Academic & Research Institute
    • 6.5.1. Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Emulate, Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. MIMETAS B.V.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Valo Health
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Quris Technologies LTD. (Nortis, Inc.)
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. AxoSim
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. BICO - THE BIO CONVERGENCE COMPANY
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. CN Bio Innovations Ltd
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. The Charles Stark Draper Laboratory, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. SynVivo, Inc.
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. AlveoliX AG
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. U.S. organ-on-a-chip market, by product & service, 2021 - 2033 (USD Million)
  • Table 3. U.S. organ-on-a-chip market, by application, 2021 - 2033 (USD Million)
  • Table 4. U.S. organ-on-a-chip market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. Organ-on-a-chip market: market outlook
  • Fig. 7 U.S. Organ-on-a-chip competitive Insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. Organ-on-a-chip market driver impact
  • Fig. 10 U.S. Organ-on-a-chip market restraint impact
  • Fig. 11 U.S. Organ-on-a-chip market: Products & service movement analysis
  • Fig. 12 U.S. Organ-on-a-chip market: Products & service outlook and key takeaways
  • Fig. 13 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Organ-on-a-chip devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Liver-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Lung-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Intestine-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Kidney-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Heart-on-a-chip market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Organ-on-a-chip market: Application movement analysis
  • Fig. 24 U.S. Organ-on-a-chip market: Application outlook and key takeaways
  • Fig. 25 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Toxicology research market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Organ-on-a-chip market: End use movement analysis
  • Fig. 29 U.S. Organ-on-a-chip market: End use outlook and key takeaways
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Academic & research institute market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2021 - 2033 (USD Million)